Michael H. B. Stowell
Founder and Director.
Biotechnology
AmideBio
United States of America
Biography
Dr. Stowell is an Associate Professor of Molecular Biology and Mechanical Engineering at the University of Colorado, Boulder and has authored a wide range of publications in the fields of synthetic organic chemistry, structural biology, neurobiology, and biophysics. Dr. Stowell has received numerous grants and awards including the Beckman Young Investigator Award, a National Institutes of Health – EUREKA award, and a Howard Hughes Medical Institute – Collaborative Innovation Award. Dr. Stowell received his Ph.D. in Chemistry and Biophysics from the California Institute of Technology and was a visiting Scientist at the MRC – Laboratory of Molecular Biology (Cambridge, England) and the Biophysics Department of Kyoto University.
Research Interest
AmideBio is a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. These include ultrastable insulin, glucose sensing insulin, solution stable glucagon and improved diagnostics for juvenile (T1) diabetes. In the diabetes space, a library of single chain insulin (SCI) analogs have been manufactured using a proprietary design protocol optimized for the production of SCI analogs that are resistant to thermal and chemical degradation at elevated temperature while maintaining maximal bioactivity